Tg Therapeutics (TGTX) EBITDA (2011 - 2026)
Tg Therapeutics (TGTX) posted quarterly EBITDA of $34.8 million for Q1 2026, up 303.56% year-over-year from $8.6 million in Q1 2025, and down 31.09% quarter-over-quarter from $50.5 million in Q4 2025.
Tg Therapeutics (TGTX) EBITDA (2011 - 2026) Analysis & Trends
Tg Therapeutics' EBITDA history runs 16 years deep, the most recent figure standing at $34.8 million for Q1 2026.
- In Q1 2026, EBITDA rose 303.56% year-over-year to $34.8 million; the TTM figure through Mar 2026 stood at $149.5 million (up 149.91% YoY), while the FY2025 annual figure was $123.3 million, up 194.13% from the prior year.
- EBITDA for Q1 2026 stood at $34.8 million, down from $50.5 million in the prior quarter.
- The five-year high for EBITDA was $114.8 million in Q3 2023, with the low at -$77.5 million in Q4 2022.
- The 5-year median for EBITDA is $8.6 million (2025), against an average of $139176.5.
- The sharpest annual moves came in 2023 and 2024: EBITDA jumped 428.3% in 2023, then slumped 89.17% in 2024.
- Tg Therapeutics' EBITDA stood at -$77.5 million in 2022, then jumped by 83.9% to -$12.5 million in 2023, then soared by 339.88% to $29.9 million in 2024, then surged by 68.6% to $50.5 million in 2025, then tumbled by 31.09% to $34.8 million in 2026.
- Business Quant data shows TGTX's EBITDA at $34.8 million in Q1 2026, $50.5 million in Q4 2025, and $29.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 493.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 325.05 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 133.12 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 231.44 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.55 Mn |
| 10 | Tg Therapeutics | 7.46 Bn | 6.78 Bn | 199.14 Mn | 21.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.67 Mn |
| Mar 31, 2026 | 34.80 Mn |
| Dec 31, 2025 | 50.49 Mn |
| Sep 30, 2025 | 29.37 Mn |
| Jun 30, 2025 | 34.84 Mn |
| Mar 31, 2025 | 8.62 Mn |
| Dec 31, 2024 | 29.95 Mn |
| Sep 30, 2024 | 12.43 Mn |
| Jun 30, 2024 | 8.82 Mn |
| Mar 31, 2024 | -9.27 Mn |
| Dec 31, 2023 | -12.49 Mn |
| Sep 30, 2023 | 114.78 Mn |
| Jun 30, 2023 | -44.67 Mn |
| Mar 31, 2023 | -36.99 Mn |
| Dec 31, 2022 | -77.54 Mn |
| Sep 30, 2022 | -34.96 Mn |
| Jun 30, 2022 | -38.94 Mn |
| Mar 31, 2022 | -66.87 Mn |
| Dec 31, 2021 | -92.95 Mn |
| Sep 30, 2021 | -85.13 Mn |